The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-3,4-dichloro-2-(cyclopropylethynyl)-1-(piperidin-3-yl)-1H-pyrrolo[2,3-b]pyridine-6-carboxamide ID: ALA4100435
PubChem CID: 137659327
Max Phase: Preclinical
Molecular Formula: C18H18Cl2N4O
Molecular Weight: 377.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CC3)n(C3CCCNC3)c2n1
Standard InChI: InChI=1S/C18H18Cl2N4O/c19-12-8-13(17(21)25)23-18-15(12)16(20)14(6-5-10-3-4-10)24(18)11-2-1-7-22-9-11/h8,10-11,22H,1-4,7,9H2,(H2,21,25)
Standard InChI Key: MPFTYTXJRHGYBP-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
12.7233 -27.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7222 -28.3561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4370 -28.7690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4352 -27.1160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1506 -27.5251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1555 -28.3515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9429 -28.6023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4249 -27.9309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9350 -27.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0075 -28.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2933 -28.3550 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0068 -29.5930 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4327 -26.2910 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.2024 -29.3854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1854 -26.4790 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.6516 -29.9971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9080 -30.7775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7154 -30.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2660 -30.3329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0092 -29.5461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2498 -27.9244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0748 -27.9195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8997 -27.9147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6141 -28.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6092 -27.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
10 11 2 0
10 12 1 0
4 13 1 0
7 14 1 0
9 15 1 0
14 16 1 0
14 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
21 22 3 0
8 21 1 0
22 23 1 0
24 23 1 0
25 24 1 0
23 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.28Molecular Weight (Monoisotopic): 376.0858AlogP: 3.13#Rotatable Bonds: 2Polar Surface Area: 72.94Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.96CX LogP: 3.17CX LogD: 0.68Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.79Np Likeness Score: -0.46
References 1. Barberis C, Moorcroft N, Pribish J, Tserlin E, Gross A, Czekaj M, Barrague M, Erdman P, Majid T, Batchelor J, Levit M, Hebert A, Shen L, Moreno-Mazza S, Wang A.. (2017) Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - Part II., 27 (20): [PMID:28927793 ] [10.1016/j.bmcl.2017.08.068 ]